Susan J. Klein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Susan J. Klein has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Guthrie S. Birkhead
8 shared publicationsAlma R. Candelas
AIDS Institute, New York State Department of Health, Albany, NY
5 shared publicationsHope A. Plavin
AIDS Institute, New York State Department of Health, Albany, NY
3 shared publicationsJames M. Tesoriero
3 shared publicationsBarbara S. Devore
2 shared publicationsJay G. Cooper
2 shared publications
Latest Publications
- 1 September 2008
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 14 (5) , 471-475
Wanted
- 1 September 2008
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 14 (5) , 471-475
Wanted
- 1 September 2008
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 14 (5) , 420-428
Screening Persons Newly Diagnosed With HIV/AIDS for Risk of Intimate Partner Violence
Interventions to prevent intimate partner violence (IPV), including among those at risk for or living with HIV/AIDS, are needed. In 2001, screening persons who test positive for HIV for risk of IPV was required in New York State, launching the first large-scale program to screen for IPV risk in conjunction with HIV counseling and testing (HCT). Written surveys of counselors, physicians, and agency supervisors explored attitudes, practices, knowledge, and training needs surrounding screening for risk of IPV during HCT. Most HCT providers were aware of screening requirements, but practice varied. Counselors were more likely to screen than were physicians and asked more screening questions. Despite guidelines, screening was generally not standardized and sporadic. IPV screening in conjunction with HCT is possible. Building capacity and commitment of local HCT providers through provision of training and by fostering partnerships with public health partner services staff can help overcome identified barriers to preventing IPV in a high-risk population.
- 1 September 2008
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 14 (5) , 420-428
Screening Persons Newly Diagnosed With HIV/AIDS for Risk of Intimate Partner Violence
Interventions to prevent intimate partner violence (IPV), including among those at risk for or living with HIV/AIDS, are needed. In 2001, screening persons who test positive for HIV for risk of IPV was required in New York State, launching the first large-scale program to screen for IPV risk in conjunction with HIV counseling and testing (HCT). Written surveys of counselors, physicians, and agency supervisors explored attitudes, practices, knowledge, and training needs surrounding screening for risk of IPV during HCT. Most HCT providers were aware of screening requirements, but practice varied. Counselors were more likely to screen than were physicians and asked more screening questions. Despite guidelines, screening was generally not standardized and sporadic. IPV screening in conjunction with HCT is possible. Building capacity and commitment of local HCT providers through provision of training and by fostering partnerships with public health partner services staff can help overcome identified barriers to preventing IPV in a high-risk population.
- 1 July 2008
- Published by SAGE Publications in Public Health Reports®
- Vol. 123 (4) , 433-440
Increasing Safe Syringe Collection Sites in New York State
This article describes expansion of options for safe syringe collection in New York State (NYS) in conjunction with efforts to enhance and expand access to hypodermic needles and syringes. Together with activities to educate the public and providers about the dangers of improperly disposed of syringes, the goals were to (1) develop community-based collection sites for individuals to safely dispose of used syringes and (2) improve accessibility of existing health-care facility-based collection sites. During the period of 2002 to 2006, 79 community-based collection sites were created. These sites collected an estimated 2.6 million used syringes during 2006. Significant increases in availability and use of health-care facility-based collection sites was also documented. Efforts to promote safe disposal in NYS are ongoing, informed by these findings.
- 1 July 2008
- Published by SAGE Publications in Public Health Reports®
- Vol. 123 (4) , 433-440
Increasing Safe Syringe Collection Sites in New York State
This article describes expansion of options for safe syringe collection in New York State (NYS) in conjunction with efforts to enhance and expand access to hypodermic needles and syringes. Together with activities to educate the public and providers about the dangers of improperly disposed of syringes, the goals were to (1) develop community-based collection sites for individuals to safely dispose of used syringes and (2) improve accessibility of existing health-care facility-based collection sites. During the period of 2002 to 2006, 79 community-based collection sites were created. These sites collected an estimated 2.6 million used syringes during 2006. Significant increases in availability and use of health-care facility-based collection sites was also documented. Efforts to promote safe disposal in NYS are ongoing, informed by these findings.
- Open Access
- 1 May 2007
- Published by SAGE Publications in Public Health Reports®
- Vol. 122 (2_suppl) , 83-88
Promoting HCV Treatment Completion for Prison Inmates: New York State's Hepatitis C Continuity Program
This article describes the development of a statewide program providing continuity of hepatitis C virus (HCV) treatment to prisoners upon release to the community. We discussed length of stay as a barrier to treatment with key collaborators; developed protocols, a referral process, and forms; mobilized staff; recruited heath-care facilities to accept referrals; and provided short-term access to HCV medications for inmates upon release. The Hepatitis C Continuity Program, including 70 prisons and 21 health-care facilities, is a resource for as many as 130 inmates eligible to start treatment annually. Health-care facilities provide fairly convenient access to 87.1% of releasees, and 100% offer integrated HCV-human immunodeficiency virus/acquired immunodeficiency syndrome care. As of March 2006, 24 inmates had been enrolled. The program was replicated in the New York City Rikers Island jail. The program is operational statewide, referrals sometimes require priority attention, and data collection and other details are still being addressed.
- 1 May 2007
- Published by SAGE Publications in Public Health Reports®
- Vol. 122 (2_suppl) , 83-88
Open AccessPromoting HCV Treatment Completion for Prison Inmates: New York State's Hepatitis C Continuity Program
This article describes the development of a statewide program providing continuity of hepatitis C virus (HCV) treatment to prisoners upon release to the community. We discussed length of stay as a barrier to treatment with key collaborators; developed protocols, a referral process, and forms; mobilized staff; recruited heath-care facilities to accept referrals; and provided short-term access to HCV medications for inmates upon release. The Hepatitis C Continuity Program, including 70 prisons and 21 health-care facilities, is a resource for as many as 130 inmates eligible to start treatment annually. Health-care facilities provide fairly convenient access to 87.1% of releasees, and 100% offer integrated HCV-human immunodeficiency virus/acquired immunodeficiency syndrome care. As of March 2006, 24 inmates had been enrolled. The program was replicated in the New York City Rikers Island jail. The program is operational statewide, referrals sometimes require priority attention, and data collection and other details are still being addressed.
- 1 January 2005
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 11 (1) , 7-17
A Public Health Approach to “Prevention With Positives”
Prevention of new HIV infections through meeting the prevention needs of HIV-infected persons, known as "prevention with positives," is a national priority. State health departments administer complex HIV/AIDS prevention, health care, and supportive service programs and shape the context for prevention services in their states. This larger context provides opportunities for development and enhancement of HIV prevention interventions. This article presents results of an assessment conducted by the New York State Department of Health of the extent to which the New York State HIV service delivery system, conceptualized as a continuum of services, supports prevention with positives and identifies opportunities for new initiatives. The New York State service continuum offers a comprehensive yet flexible framework into which effective HIV prevention interventions and services are embedded. It is mobilized in support of meeting individuals' HIV prevention needs. The service continuum continues to evolve and requires constant attention on the part of New York State Department of Health to keep pace with the ever-changing HIV epidemic. Additional features of New York State's comprehensive approach to prevention with positives are also discussed. This simple assessment, which can be adapted for use elsewhere, was effective in pinpointing how the current service delivery system supports prevention with positives. Approaches used by state health departments to advance prevention with positives warrant support and recognition.
- 1 January 2005
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 11 (1) , 7-17
A Public Health Approach to “Prevention With Positives”
Prevention of new HIV infections through meeting the prevention needs of HIV-infected persons, known as "prevention with positives," is a national priority. State health departments administer complex HIV/AIDS prevention, health care, and supportive service programs and shape the context for prevention services in their states. This larger context provides opportunities for development and enhancement of HIV prevention interventions. This article presents results of an assessment conducted by the New York State Department of Health of the extent to which the New York State HIV service delivery system, conceptualized as a continuum of services, supports prevention with positives and identifies opportunities for new initiatives. The New York State service continuum offers a comprehensive yet flexible framework into which effective HIV prevention interventions and services are embedded. It is mobilized in support of meeting individuals' HIV prevention needs. The service continuum continues to evolve and requires constant attention on the part of New York State Department of Health to keep pace with the ever-changing HIV epidemic. Additional features of New York State's comprehensive approach to prevention with positives are also discussed. This simple assessment, which can be adapted for use elsewhere, was effective in pinpointing how the current service delivery system supports prevention with positives. Approaches used by state health departments to advance prevention with positives warrant support and recognition.
- 1 November 2002
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 42 (6) , S28-S29
Mobilizing public and private partners to support New York's Expanded Syringe Access Demonstration Program.
- 1 November 2002
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 42 (6) , S28-S29
Mobilizing public and private partners to support New York's Expanded Syringe Access Demonstration Program.
- 1 November 2002
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 42 (6) , S29-S31
Maximizing the Benefits of Expanded Syringe Access and Safe Disposal for Persons with Diabetes
- 1 November 2002
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 42 (6) , S29-S31
Maximizing the Benefits of Expanded Syringe Access and Safe Disposal for Persons with Diabetes
- 1 November 2002
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 42 (6) , S105-S107
Promoting Safe Syringe Disposal Goes “Hand in Hand” with Expanded Syringe Access in New York State
- 1 November 2002
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 42 (6) , S105-S107
Promoting Safe Syringe Disposal Goes “Hand in Hand” with Expanded Syringe Access in New York State
- 1 October 2002
- Published by Guilford Publications in AIDS Education and Prevention
- Vol. 14 (5_suppleme) , 114-123
Building an HIV Continuum for Inmates: New York State's Criminal Justice Initiative
The benefits of public health, corrections, and community-based organization (CBO) collaboration to meet HIV prevention needs of inmates are recognized. Each year over 100,000 inmates, mos...
- 1 October 2002
- Published by Guilford Publications in AIDS Education and Prevention
- Vol. 14 (5_suppleme) , 114-123
Building an HIV Continuum for Inmates: New York State's Criminal Justice Initiative
The benefits of public health, corrections, and community-based organization (CBO) collaboration to meet HIV prevention needs of inmates are recognized. Each year over 100,000 inmates, mos...
- Open Access
- 1 December 2001
- Published by Springer Nature in Journal of Urban Health
- Vol. 78 (4) , 679-689
What do pharmacists think about New York State's new nonprescription syringe sale program? Results of a survey
Access to sterile syringes can prevent transmission of blood-borne diseases such as human immunodeficiency virus (HIV) and hepatitis B and C. We conducted a survey of attitudes of pharmacists to aid, in development of the Expanded. Syringe Access Demonstration Program (ESAP) in New York State. ESAP is an HIV prevention initiative that authorizes nonprescription sale of hypodermic needles and syringes by registered pharmacies in New York State beginning January 1, 2001. As part of planning for program implementation, the New York State Department of Health (NYSDOH), in collaboration with the New York State Education Department, conducted a mailed survey of all 4,392 licensed pharmacies in New York State during the summer of 2000. Some surveys (171) were returned as undeliverable. Of the 4,221 eligible respondents, 874 (20.7%) completed surveys were received, of which 574 (65.7%) indicated that their pharmacy would likely participate in ESAP. An additional 11.0% were not sure. Only 139 (15.9%) indicated that they would definitely not participate; 7.4% left this question blank. There were 608 responses to questions on safe disposal practices. Of these, 315 (51.8%) respondents indicated that their pharmacy sold sharps containers, and an additional 29 made them available at no cost. Only 133 (21.9%) respondents to this question did not offer sharps containers and were not interested in doing so. In all, 54 responses indicated that they accepted used hypodernmic needles and syringesfor disposal. Some (170, 28%) that did not accept shaprs for disposal were interested in doing so. More than half (382, 63.0%) did not wish to do so. NYSDOH considered respondent suggestions and minimized ESAP requirements. By March 31, 2001, only 3 months after ESAP became effective, more than half of all licensed pharmacies in New York State were registered for ESAP. Survey results provided useful information to NYSDOH and a good indication of likelihood of registration. The high level of pharmacy participation in ESAP may be reflective of NYSDOH attention to issues raised by pharmacists, as well as the direct effects of outreach to pharmacy chains regarding ESAP.
- 1 December 2001
- Published by Springer Nature in Journal of Urban Health
- Vol. 78 (4) , 679-689
Open AccessWhat do pharmacists think about New York State's new nonprescription syringe sale program? Results of a survey
Access to sterile syringes can prevent transmission of blood-borne diseases such as human immunodeficiency virus (HIV) and hepatitis B and C. We conducted a survey of attitudes of pharmacists to aid, in development of the Expanded. Syringe Access Demonstration Program (ESAP) in New York State. ESAP is an HIV prevention initiative that authorizes nonprescription sale of hypodermic needles and syringes by registered pharmacies in New York State beginning January 1, 2001. As part of planning for program implementation, the New York State Department of Health (NYSDOH), in collaboration with the New York State Education Department, conducted a mailed survey of all 4,392 licensed pharmacies in New York State during the summer of 2000. Some surveys (171) were returned as undeliverable. Of the 4,221 eligible respondents, 874 (20.7%) completed surveys were received, of which 574 (65.7%) indicated that their pharmacy would likely participate in ESAP. An additional 11.0% were not sure. Only 139 (15.9%) indicated that they would definitely not participate; 7.4% left this question blank. There were 608 responses to questions on safe disposal practices. Of these, 315 (51.8%) respondents indicated that their pharmacy sold sharps containers, and an additional 29 made them available at no cost. Only 133 (21.9%) respondents to this question did not offer sharps containers and were not interested in doing so. In all, 54 responses indicated that they accepted used hypodernmic needles and syringesfor disposal. Some (170, 28%) that did not accept shaprs for disposal were interested in doing so. More than half (382, 63.0%) did not wish to do so. NYSDOH considered respondent suggestions and minimized ESAP requirements. By March 31, 2001, only 3 months after ESAP became effective, more than half of all licensed pharmacies in New York State were registered for ESAP. Survey results provided useful information to NYSDOH and a good indication of likelihood of registration. The high level of pharmacy participation in ESAP may be reflective of NYSDOH attention to issues raised by pharmacists, as well as the direct effects of outreach to pharmacy chains regarding ESAP.